Date Filed | Type | Description |
10/06/2023 |
4
| Kelly William John (CFO and Treasurer) has filed a Form 4 on Vicarious Surgical Inc.
Txns:
| Sold 4,858 shares
@ $0.4873, valued at
$2.4k
|
|
10/05/2023 |
144
| Form 144 - Report of proposed sale of securities: |
10/03/2023 |
4
| Ho David D (Director) has filed a Form 4 on Vicarious Surgical Inc.
Txns:
| Granted 7,410 shares
@ $0 Granted 22,959 shares
@ $0 |
|
08/25/2023 |
4
| Morris June (CLO, GC and Secretary) has filed a Form 4 on Vicarious Surgical Inc.
Txns:
| Sold 2,500 shares
@ $0.951, valued at
$2.4k
|
|
08/24/2023 |
144
| Form 144 - Report of proposed sale of securities: |
08/22/2023 |
4
| Khalifa Sammy (Chief Technology Officer) has filed a Form 4 on Vicarious Surgical Inc.
Txns:
| Sold 19,401 shares
@ $0.9232, valued at
$17.9k
|
|
08/22/2023 |
4
| Morris June (CLO, GC and Secretary) has filed a Form 4 on Vicarious Surgical Inc.
Txns:
| Sold 6,407 shares
@ $0.9244, valued at
$5.9k
|
|
08/22/2023 |
4
| Kelly William John (CFO and Treasurer) has filed a Form 4 on Vicarious Surgical Inc.
Txns:
| Sold 6,478 shares
@ $0.9259, valued at
$6k
|
|
08/22/2023 |
4
| Sachs Adam David (President and CEO) has filed a Form 4 on Vicarious Surgical Inc.
Txns:
| Sold 24,251 shares
@ $0.9093, valued at
$22.1k
|
|
08/21/2023 |
144
| Form 144 - Report of proposed sale of securities: |
08/21/2023 |
144
| Form 144 - Report of proposed sale of securities: |
08/21/2023 |
144
| Form 144 - Report of proposed sale of securities: |
08/21/2023 |
144
| Form 144 - Report of proposed sale of securities: |
08/15/2023 |
SC 13G/A
| SUN HUNG KAI & CO LTD reports a 4.1% stake in Vicarious Surgical Inc. |
08/11/2023 |
3
| Gates Frontier, LLC (10% Owner) has filed a Form 3 on Vicarious Surgical Inc. |
08/09/2023 |
4
| Khosla Ventures V, L.P. (10% Owner) has filed a Form 4 on Vicarious Surgical Inc.
Txns:
| Bought 8,000,000 shares
@ $1, valued at
$8M
|
|
08/09/2023 |
SC 13D/A
| Khosla Ventures V, L.P. reports a 19% stake in Vicarious Surgical Inc. |
08/09/2023 |
4
| Kelly William John (CFO and Treasurer) has filed a Form 4 on Vicarious Surgical Inc.
Txns:
| Sold 4,985 shares
@ $0.8614, valued at
$4.3k
|
|
08/07/2023 |
144
| Form 144 - Report of proposed sale of securities: |
08/04/2023 |
8-K
| Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits Interactive Data
Docs:
|
"$45,000,000 OF SHARES OF",
"OPINION OF MINTZ, LEVIN, COHN, FERRIS, GLOVSKY AND POPEO, P.C",
"Vicarious Surgical Announces Launch of Proposed Public Offering WALTHAM, Mass, August 2, 2023 – Vicarious Surgical Inc. , a next-generation robotics technology company seeking to improve patient outcomes as well as both the cost and efficiency of surgical procedures, today announced that it has commenced an underwritten public offering of $45.0 million of shares of its Class A common stock . All of the shares of Common Stock are being offered by Vicarious Surgical. In addition, the Company has granted the underwriters a 30-day option to purchase up to $6.75 million of additional shares of its Common Stock. Morgan Stanley & Co. LLC and Cowen and Company, LLC are acting as joint book-running managers for the offering. The proposed offering is subject to market and other conditions, and there...",
"Vicarious Surgical Announces Pricing of Public Offering WALTHAM, Mass, August 2, 2023 – Vicarious Surgical Inc. , a next-generation robotics technology company seeking to improve patient outcomes as well as both the cost and efficiency of surgical procedures, today announced the pricing of its underwritten public offering of 45,000,000 shares of its Class A common stock at a price to the public of $1.00 per share. In addition, Vicarious Surgical has granted the underwriters a 30-day option to purchase up to an additional 6,750,000 shares of its Common Stock. Before deducting the underwriting discounts and commissions and estimated offering expenses, the Company expects to receive total gross proceeds of approximately $45.0 million, assuming no exercise of the underwriters’ option to purcha..." |
|
08/04/2023 |
424B5
| Form 424B5 - Prospectus [Rule 424(b)(5)]: |
08/02/2023 |
424B5
| Form 424B5 - Prospectus [Rule 424(b)(5)]: |
07/28/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
07/27/2023 |
8-K
| Investor presentation |
07/27/2023 |
8-K
| Quarterly results |
07/06/2023 |
4
| Kelly William John (CFO and Treasurer) has filed a Form 4 on Vicarious Surgical Inc.
Txns:
| Sold 4,859 shares
@ $1.827, valued at
$8.9k
|
|
07/05/2023 |
144
| Form 144 - Report of proposed sale of securities: |
06/07/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
06/06/2023 |
4
| Mazzola John (COO) has filed a Form 4 on Vicarious Surgical Inc.
Txns:
| Granted 319,230 shares
@ $0 |
|
06/06/2023 |
4
| Sachs Adam David (President and CEO) has filed a Form 4 on Vicarious Surgical Inc.
Txns:
| Granted 647,266 shares
@ $0 |
|
06/06/2023 |
4
| Morris June (CLO, GC and Secretary) has filed a Form 4 on Vicarious Surgical Inc.
Txns:
| Granted 300,479 shares
@ $0 |
|
06/06/2023 |
4
| Khalifa Sammy (Chief Technology Officer) has filed a Form 4 on Vicarious Surgical Inc.
Txns:
| Granted 333,852 shares
@ $0 |
|
06/06/2023 |
4
| Kelly William John (CFO and Treasurer) has filed a Form 4 on Vicarious Surgical Inc.
Txns:
| Granted 304,049 shares
@ $0 Sold 4,869 shares
@ $2.1847, valued at
$10.6k
|
|
06/05/2023 |
4
| Styka David Michael (Director) has filed a Form 4 on Vicarious Surgical Inc.
Txns:
| Granted 65,974 shares
@ $0 Granted 32,987 shares
@ $0 |
|
|